v3.25.2
RESTATEMENT OF PREVIOUSLY ISSUED CONSOLIDATED FINANCIAL STATEMENTS AND PREVIOUSLY ISSUED UNAUDITED INTERIM CONDENSED CONSOLIDATED FINANCIAL STATEMENTS - Consolidated Balance Sheets (Details) - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Sep. 30, 2024
Jun. 30, 2024
Mar. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT              
Accrued expenses $ 4,302,642 $ 4,301,195 $ 4,198,182 $ 4,070,313 $ 3,002,645 $ 2,499,657  
Current portion of notes payable 5,645,824 9,242,183       2,147,992  
Total current liabilities 40,288,082 20,788,893 15,427,675 13,256,029 12,195,124 9,778,040  
Convertible notes payable     4,683,068 5,589,468 6,967,951 6,967,951  
Total liabilities 40,289,397 20,917,508 20,193,076 19,297,504 21,518,002 19,221,879  
Additional paid-in capital 99,033,289 93,968,071 [1]       64,744,838 [1]  
Accumulated deficit (138,019,980) (131,806,605) (120,020,555) (115,626,325) (102,991,887) (97,290,851)  
Total Stockholders' Deficit (38,977,924) $ (37,836,506) (36,311,850) (34,793,016) (37,434,715) (32,545,921) $ (17,234,376)
Originally Reported [Member]              
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT              
Accrued expenses     4,443,179 4,316,645 3,248,847 2,750,305  
Current portion of notes payable 3,655,568            
Total current liabilities 38,297,826   15,672,672 13,502,361 12,441,326 10,028,688  
Convertible notes payable     4,511,880 5,385,147 6,713,241 6,713,241  
Total liabilities 38,299,141   20,266,885 19,339,515 21,509,495 19,217,817  
Additional paid-in capital 98,432,170            
Accumulated deficit (135,428,605)   (120,052,352) (115,674,830) (102,987,442) (97,286,789)  
Total Stockholders' Deficit (36,987,668)   (36,343,647) (34,841,521) (37,430,270) (32,541,859)  
Restatement Adjustment [Member] | Senior Convertible Notes [Member]              
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT              
Accrued expenses     (244,997) (246,332) (246,202) (250,648)  
Total current liabilities     (244,997) (246,332) (246,202) (250,648)  
Convertible notes payable     171,188 204,321 254,710 254,710  
Total liabilities     (73,809) (42,011) 8,507 4,062  
Accumulated deficit     31,797 48,505 (4,445) (4,062)  
Total Stockholders' Deficit     $ 31,797 $ 48,505 $ (4,445) $ (4,062)  
Restatement Adjustment [Member] | Indigo Convertible Notes [Member]              
LIABILITIES, CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS' DEFICIT              
Current portion of notes payable 1,990,256            
Total current liabilities 1,990,256            
Total liabilities 1,990,256            
Additional paid-in capital 601,119            
Accumulated deficit (2,591,375)            
Total Stockholders' Deficit $ (1,990,256)            
[1] Amount presented as of December 31, 2023 is adjusted to reflect the 1-for-40 reverse stock split on July 23, 2024. See Note 2 – Summary of Significant Accounting Policies for additional information.